ArticleJCI insight2022

Targeting CAR and Nrf2 improves cyclophosphamide bioactivation while reducing doxorubicin-induced cardiotoxicity in triple-negative breast cancer treatment.

Sydney Stern et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.